Page results
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
From May 2021 north central London (NCL) has implemented a new model for elective orthopaedic care. This follows a review of adult elective orthopaedic services and is the culmination of three years collaboration with NHS providers to improve services for patients.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
-
This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Transforming UCLH into a truly digitally integrated hospital has paid dividends during our response to COVID-19. We are one of a handful of trusts to have done this.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
You can use MyCare on your mobile, tablet or computer to securely view and manage information about your health and care at UCLH.
File results
-
FOI/2019/524 UCLH Phase 5 contractors
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways
-
FOI/2019/514 Benchmarking tool
-
FOI/2019/484 Homless patients admitted to ED
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology